Altos Labs IPO

altoslabs.comHealthcare / BioTech & Pharma

Altos Labs was founded in 2021 by Hans Bishop and Richard Klausner. Altos Labs has not publicly endorsed a plan to participate in an IPO.

Altos Labs is a biotech company with a focus on cellular rejuvenation programming to restore cell health and resilience. Per Forge data, the most recent funding for Altos Labs was in January 2021. Their total funding raised is $3 billion. Key investors include ARCH Venture Partners.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Buy or sell Altos Labs stock Learn more about Altos Labs stock

Learn more about Altos Labs

Is Altos Labs a publicly traded company?

Altos Labs is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Will Altos Labs go IPO?

Altos Labs has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Altos Labs's IPO price?

The IPO price for Altos Labs will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.

Can you invest in Altos Labs pre-IPO?

Altos Labs is privately held company and is not publicly traded, therefor investing in Altos Labs pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

What is the value of my Altos Labs shares?

To determine the value of your Altos Labs shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Altos Labs shares. You can also learn more about how to sell your private shares before getting started.

Can you sell Altos Labs before it goes public?

Yes, you can seek to sell shares in Altos Labs while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is Altos Labs's funding to date?

Altos Labs has raised $2.62B to date.

When was Altos Labs founded?

Altos Labs was founded in 2021.

Did Jeff Bezos invest in Altos Labs?

Jeff Bezos invested in Altos Labs in 2022.

What does Altos Labs do?

Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.

Who is the CEO of Altos Labs?

The CEO of Altos Labs is Hal Barron.

Who are Altos Labs's major investors?

Arch Venture Partners

Foresite Capital

Mubadala Investment Company

Altos Labs funding rounds and last known valuation

Date	Funding Round	Funding Raised	Price per Share	Last Known Valuation
2/14/2024	Series C	$1.5B raised	$XXX.XX	$XXX.XX
3/25/2022	Series B	$818.78MM raised	$XXX.XX	$XXX.XX
9/4/2021	Series A	$305.91MM raised	$XXX.XX	$XXX.XX

Based on primary financings

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.